As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc., could charge up to $10,000 for the treatment. Then a small but increasingly …
Medication costs for COVID-19 patients hospitalized in the United States have dropped sharply since May, reflecting advances in treatment, shorter stays and use of cheaper generic drugs. But costs may rise again as hospitals start to pay for Gilead Sciences …
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. …
The chair of a House of Representatives committee and a fellow Democratic committee member on Monday urged Jaguar Health Inc. to reverse recent price hikes of a drug that could be used to treat side effects in COVID-19 patients and …
